PANAGORA ASSET MANAGEMENT INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 175 filers reported holding HAEMONETICS CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,832,859
-21.6%
42,787
-27.6%
0.02%
-22.6%
Q1 2023$4,891,849
-68.7%
59,116
-70.3%
0.03%
-69.9%
Q4 2022$15,638,215
+7.3%
198,833
+1.0%
0.10%
+2.0%
Q3 2022$14,577,000
+3.9%
196,900
-8.5%
0.10%
+9.8%
Q2 2022$14,030,000
-5.8%
215,253
-8.7%
0.09%
+13.6%
Q1 2022$14,897,000
+25.8%
235,638
+5.5%
0.08%
+28.6%
Q4 2021$11,846,000
-25.3%
223,347
-0.6%
0.06%
-25.9%
Q3 2021$15,868,000
+4.5%
224,793
-1.4%
0.08%
+4.9%
Q2 2021$15,190,000
+12772.9%
227,937
+21342.8%
0.08%
+8000.0%
Q1 2021$118,000
-78.2%
1,063
-76.7%
0.00%
-66.7%
Q4 2020$541,000
-27.1%
4,558
-46.4%
0.00%
-40.0%
Q3 2020$742,000
-60.6%
8,502
-59.5%
0.01%
-58.3%
Q2 2020$1,881,000
-73.2%
21,002
-70.1%
0.01%
-76.0%
Q1 2020$7,007,000
-5.6%
70,310
+8.8%
0.05%
+47.1%
Q4 2019$7,424,000
-32.7%
64,611
-26.1%
0.03%
-33.3%
Q3 2019$11,032,000
-66.2%
87,457
-67.8%
0.05%
-65.1%
Q2 2019$32,647,000
-28.2%
271,293
-47.8%
0.15%
-27.7%
Q1 2019$45,482,000
-29.4%
519,909
-19.2%
0.20%
-32.7%
Q4 2018$64,382,000
-20.1%
643,503
-8.4%
0.30%
-1.0%
Q3 2018$80,530,000
+22.2%
702,826
-4.3%
0.30%
+16.1%
Q2 2018$65,885,000
+13.6%
734,672
-7.4%
0.26%
+14.0%
Q1 2018$58,015,000
+27.3%
792,990
+1.0%
0.23%
+33.9%
Q4 2017$45,587,000
+45.0%
784,893
+12.0%
0.17%
+36.8%
Q3 2017$31,448,000
+7.0%
700,866
-5.9%
0.12%
+5.9%
Q2 2017$29,397,000
-14.8%
744,419
-12.5%
0.12%
-18.1%
Q1 2017$34,504,000
+48.2%
850,479
+46.8%
0.14%
+34.6%
Q4 2016$23,283,000
+29.8%
579,174
+17.0%
0.11%
+25.9%
Q3 2016$17,931,000
+321.3%
495,202
+237.3%
0.08%
+304.8%
Q2 2016$4,256,000
-8.2%
146,811
+10.8%
0.02%
-8.7%
Q1 2016$4,637,000
+1.4%
132,552
-6.5%
0.02%0.0%
Q4 2015$4,571,000
-0.2%
141,7750.0%0.02%
-4.2%
Q3 2015$4,582,000
-20.5%
141,775
+1.7%
0.02%
-17.2%
Q2 2015$5,766,000
-14.2%
139,412
-6.9%
0.03%
-14.7%
Q1 2015$6,723,000
-12.0%
149,665
-26.7%
0.03%
-12.8%
Q4 2014$7,643,000
+114.6%
204,247
+100.2%
0.04%
+129.4%
Q3 2014$3,562,000
-44.2%
102,007
-43.6%
0.02%
-45.2%
Q2 2014$6,378,000
+80.9%
180,788
+67.1%
0.03%
+82.4%
Q1 2014$3,525,000108,1640.02%
Other shareholders
HAEMONETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders